Literature DB >> 20051733

Upper respiratory tract infection symptoms in ultramarathon runners not related to immunoglobulin status.

Edith M Peters1, Junaid Shaik, Neil Kleinveldt.   

Abstract

OBJECTIVE: To determine the association between variation in exercise load, immunoglobulin (Ig) status, and self-reported symptoms of upper respiratory tract infection (URTI) in ultramarathon runners.
DESIGN: Longitudinal observational field study.
SETTING: Four weeks before and 2 weeks after an 86.5-km Comrades Marathon, South Africa. PARTICIPANTS: Fourteen randomly selected, amateur, male, ultramarathon runners. MAIN OUTCOME MEASURES: Daily record of training and URTI symptom incidence. Salivary IgA and IgM at 28 days, 14 days, and 1 day (01PRE) before the race, immediately post race (IPR) and 1 (01 PR), 3, and 14 days post race. Serum cortisol, IgG, IgM, and IgA concentrations at 01PRE, IPR, and 01PR.
RESULTS: Mean weekly training distance varied from 89.4 kilometers per week (28.9 kilometers per week) to 4.2 kilometers per week (6.7 kilometers per week). Absolute and relative mucosal IgA and IgM concentrations were unaffected by pre-race taper in training volume (P > 0.05). IgA and IgM secretion rates decreased post race (P = 0.018; 0.008), returning to baseline by 01PR. Blood leukocyte, serum cortisol, and serum IgG concentrations increased at IPR (P < 0.001, <0001) and 01PR (P = 0.009), respectively. Upper respiratory tract infection symptom incidence was highest at 28PRE and 7 to 14 days post race but not related to salivary IgA and IgM secretion rates. Eight subjects (57%) who reported URTI symptoms pre race also reported these during days 7 to 14 post race.
CONCLUSIONS: Upper respiratory tract infection symptom incidence was not associated with secretory Ig concentrations. Reactivation of pre-race viruses during the 2 weeks post race and exercise-induced inflammatory response are proposed as causes of the elevated URTI incidence at 28PRE and 7 to 14 days post race.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051733     DOI: 10.1097/JSM.0b013e3181cb4086

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  8 in total

Review 1.  Realising the Potential of Urine and Saliva as Diagnostic Tools in Sport and Exercise Medicine.

Authors:  Angus Lindsay; Joseph T Costello
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

2.  The Effect of a 100-km Ultra-Marathon under Freezing Conditions on Selected Immunological and Hematological Parameters.

Authors:  Alena Žákovská; Beat Knechtle; Daniela Chlíbková; Marie Miličková; Thomas Rosemann; Pantelis T Nikolaidis
Journal:  Front Physiol       Date:  2017-09-12       Impact factor: 4.566

Review 3.  Physiology and Pathophysiology in Ultra-Marathon Running.

Authors:  Beat Knechtle; Pantelis T Nikolaidis
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

4.  Acute and chronic effects of physical exercise on IgA and IgG levels and susceptibility to upper respiratory tract infections: a systematic review and meta-analysis.

Authors:  Lucas Rios Drummond; Helton Oliveira Campos; Filipe Rios Drummond; Gabriel Moraes de Oliveira; João Guilhermo Rios Pimenta Fernandes; Rodrigo Prates Amorim; Mateus da Costa Monteiro; Henrique Fernandes Gerspacher Lara; Laura Hora Rios Leite; Cândido Celso Coimbra
Journal:  Pflugers Arch       Date:  2022-10-17       Impact factor: 4.458

5.  Salivary antimicrobial protein response to prolonged running.

Authors:  T L Gillum; M Kuennen; C Gourley; S Schneider; K Dokladny; P Moseley
Journal:  Biol Sport       Date:  2013-01-21       Impact factor: 2.806

6.  Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.

Authors:  Brian K McFarlin; Katie C Carpenter; Tiffany Davidson; Meredith A McFarlin
Journal:  J Diet Suppl       Date:  2013-08-09

Review 7.  Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan.

Authors:  John P Campbell; James E Turner
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

Review 8.  Behavioral strategies to prevent and mitigate COVID-19 infection.

Authors:  Noah T Hutchinson; Andrew Steelman; Jeffrey A Woods
Journal:  Sports Med Health Sci       Date:  2020-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.